ClinicaSpace Focus
   Wednesday, May 07, 2008 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
TOP SPONSOR

DIA Annual Convention:

Join more than 8,000 attendees as they share information about the latest innovations in drug development and search for solutions to industry challenges.

Highlights of this year's event:
• Over 360 sessions across 26 content areas
• 40 preconference tutorials
• Over 1000 speakers, including representatives from FDA, EMEA, and other global regulatory agencies
• 500+ exhibiting companies
• Networking Reception at the Boston Museum of Science

Please click here for more information.
HeadHtml
•  Astellas Pharma Inc. Says U.S. Not Ready to Approve Transplant Drug More...
•  Cephalon, Inc. (CEPH) Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA More...
•  Acucela Inc. Files Investigational New Drug Application More...
•  Oscient Pharmaceuticals Corporation (OSCI) Release: Regulatory Filing for FACTIVE Tablets Submitted in Europe More...
•  Osteologix Inc. IND for NB S101 for Osteoporosis Accepted by FDA More...

More BLA/NDA/ANDA News
More IND News
More MAA News
HeadHtml
•  Mylan Laboratories Inc. (MYL) Announces Final FDA Approval for Ropinirole Hydrochloride Tablets More...
•  Trudell Innovation to Benefit U.S. Asthma Patients More...

More Drug Approval News
HeadHtml
•  Orexigen Therapeutics, Inc. (OREX) Announces Completion of Patient Enrollment in Phase III Clinical Program for Contrave(R) More...
•  Johnson and Johnson Pharmaceutical Research and Development, LLC (CA) Seven Clinical Presentations on Tapentadol Immediate Release for Acute Pain to Be Featured at 2008 American Pain Society Annual Meeting More...
•  Indevus Pharmaceuticals, Inc. (IDEV) Two Year Study Confirms SUPPRELIN(R) LA Implant Maintains Profound Suppression of Hormones in Children With Premature Onset Puberty More...
•  Vanda Pharmaceuticals, Inc. (VNDA) Data Presented at the American Psychiatric Association Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events More...
•  LifeCycle Pharma Announces Positive Data from LCP-AtorFen Phase II Clinical Program More...

More Phase III News
More Phase II News
More Phase I News
More Pre-Clinical News
More Post-Approval News
HeadHtml
•  Champions Biotechnology, Inc. (CSBR) and ImClone Systems Incorporated (IMCL) Establish Agreement for Preclinical Evaluation of Oncology Drugs More...
•  Pharm-Olam International Ltd. Finds VoIP Solution in Taridium LLC More...
•  Apotex Corp. Receives Final Tender Approval From Rwanda For Vital AIDS Drug More...
•  Advanced BioHealing, Inc. and Regenesis Biomedical Form Co-Promotion Alliance More...

More Alliances News
HeadHtml
•  Par Pharmaceutical Companies, Inc. (PRX) To Pay Spectrum Pharmaceuticals, Inc. (SPPI) $20M For Its Stake In Generic Injection More...
•  iCo Therapeutics Inc. Acquires Worldwide Rights to iCo-009 (Oral Amphotericin B) More...
•  Mistral Pharma Inc. Announces It will Not Combine with a Private U.S. Pharmaceutical Company More...
•  ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer HealthCare (BAY) More...

More Mergers & Acquisitions News
Latest Market Insight
Drug Approval Trends at the FDA and EMEA

Process improvements, heightened scrutiny and industry response

• Delayed approvals. Regulators are requesting more data to validate or refute conclusions about product risks. This is creating a rise in the size and number of clinical trials as well as overall research budgets.

• Rising R&D costs. Drug developers are continually increasing their R&D expenditures to generate approvable drug applications, despite rising financial pressures in the industry. Emerging technologies such as stem cells, genomics and proteomics are among the most prevalent initiatives being used to identify appropriate drug candidates.

• US generics focus. The FDA is allocating resources to generic drug approvals in an attempt to speed these products to market. However, although Europe has recently developed a clear regulatory path for generic versions of biologicals, this is yet be achieved in the US.

• Regulatory process improvements. Regulators are enhancing their drug review processes with new technologies such as electronic drug applications and technology-based standards for drug review.

Click Here for More Information

What Are You Worth?
Top Jobs
BioTechxus (Fort Worth, Texas) Hot Job of the Day:

Alcon Laboratories
Clinical Team Leader
Implement clinical pharmacology studies and project-related activities to support the clinical evaluation of Alcon lead candidates. Provide strong leadership to subordinates and facilitate and support their roles within the CP Unit.

Biotech Beach (Irvine, California) Hot Job of the Day:

ClinAssure, Inc.
Senior Clinical Research Associate ( Senior CRA )
As a member of the clinical team under supervision, this position is responsible for performing clinical research activities related to all clinical research studies and projects according to Federal Regulations and ICH guidelines.

Genetown (Cambridge, Massachusetts) Hot Job of the Day:

Clinical Brokers
Clinical Project Manager
The Study Manager manages and leads a cross-functional Study Team for the entire duration of the study. The overall objective of the Study Manager is to manage the planning, implementation, analysis and reporting of assigned less complex global and local studies within the established timeframes and budget, with the quality and requirements necessary for global regulatory approvals.

Pharm Country (Parsippany, New Jersey) Hot Job of the Day:

Daiichi-Sankyo
Study Manager, Clinical Pharmacology
The incumbent will be responsible for the implementation and day-to-day coordination of TMCP studies conducted in North America and Europe. Drug candidates under investigation may belong to any therapeutic area.

Biotech Bay (Berkeley, California) Hot Job of the Day:

University of California, Berkeley (CAL)
Teaching Lab Research Associate III
The Teaching Lab Research Associate will work in the Instructional Lab Support Unit and is responsible for the organization and preparation of the undergraduate Immunology Laboratory course (MCB 150L).

Get Noticed! Add your resume to the BioSpace Career Center!
See more than 5,000 job postings in the BioSpace Career Center!

BioSpace.com is pleased to present the Boehringer Ingelheim Career Fair on Thursday, May 8th at The Sheraton Boston Hotel in Boston, Massachusetts from 11:00 a.m. to 4:00 p.m. You must pre-register in order to attend this event.

For this event, Boehringer Ingelheim is ONLY interviewing candidates with the following backgrounds:

• Immunology/Inflammatory Disease Research - Scientists with BS, MS, and/or PhD
• Medicinal Chemistry - Scientists and Principal Scientists with MS or PhD
• Cardiovascular Disease Research - Scientists and Principal Scientists with MS or PhD
• Translational Sciences - Director level with PhD experience in Systems Biology and/or Electronic Biology
• Biologics/Biomolecular Sciences - Scientists and Principal Scientists with BS, MS, or Ph.D. and experience in Antibody/protein engineering
• Animal Resources - Facility Managers with BS and GLP experience
• Clinical Trial Support - Scientists with BS or MS degree in related field

We look forward to seeing you at the Boehringer Ingelheim Career Fair!

Boehringer Ingelheim Career Fair, May 8, 2008
Pharm Country Career Fair, June 5, 2008
DDT - BioSpace 2008 Career Fair, August 6, 2008
DeviceSpace Career Fair, September 8, 2008
BioCapital Career Fair, September 30, 2008
Biotech Bay Career Fair, October 14, 2008

More information about BioSpace's Career Fairs
HeadHtml
•  Pipex Pharmaceuticals (PPXP) Announces Notice of Allowance of U.S. Patent for Oral TTM for Alzheimer's Disease More...
•  Critical Outcome Technologies Inc. Announces Granting of European Patents for Acute Myelogenous Leukemia Drug Candidates More...
•  VioQuest Pharmaceuticals, Inc. (VQPH.OB) Announces Issuance of U.S. Patent More...
•  Lipid Sciences, Inc. (LIPD) Broadens Intellectual Property Portfolio With Two New Patents More...

More Patent News
Events
Drug Development Clearly Explained

• Clear text explaining all aspects of global development, from laboratory to market hyperlinked to relevant guidelines
• Suitable for scientists, developers, business people wanting a clear but comprehensive summary.
• 21 Chapters, with key points and questions/answers to insure understanding
• E-book/pdf format/secure download only

250 pages plus 1800 page appendix. $295/EUR190; corporate licences for multiple users available.

www.alladex.com
Feature
Hot Company



Vertex Pharmaceuticals Incorporated
11010 Torreyana Road
San Diego, California 92121 U.S.A.
Phone: 858-404-6600 Fax: 858-404-6726
View Jobs

Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company’s strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex’s product pipeline is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain, cystic fibrosis and bacterial infection. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply join the ClinicaSpace Focus here.

Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here or by clicking on the "unsubscribe" link at the bottom of this newsletter.
Contact Us
Send questions and comments to the ClinicaSpace NewsBeat Team East Coast Office:
    ClinicaSpace
    Ramshorn Executive Centre
    2399 Highway 34, Building A-5
    Manasquan, New Jersey 08736-1528 U.S.A.
    Phone: 732-528-3688
    Fax: 732-528-3668
West Coast Office:
    ClinicaSpace
    90 New Montgomery Street, Suite 414
    San Francisco, California 94105 U.S.A.
    Phone: 877-277-7585
    Fax: 415-576-9217
Editor & Publisher:
    Rosemary Do
Editorial & Production Staff:
    Annalyn Aquino
    Suvarna Bhatt
    Lana Ho
ClinicaSpace.com - The Most Trusted Source for Daily Clinical News
Legal Notice
• ClinicaSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2008 ClinicaSpace http://www.clinicaspace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.